1 Tamura A, "Yerba-mate (Ilex paraguariensis) extract prevents ethanol-induced liver injury in rats" 5 : 1714-1723, 2013
2 김지호, "Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K" 한국응용약물학회 21 (21): 234-240, 2013
3 Azevedo MF, "Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3" 24 (24): 220-224, 2010
4 Schwartz JE, "The measurement of fatigue:a new instrument" 37 : 753-762, 1993
5 Rambaldi A, "S-adenosyl-L-methionine for alcoholic liver diseases" CD002235-, 2006
6 Becker U, "Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study" 23 : 1025-1029, 1996
7 Conigrave KM, "Prediction of alcohol-related harm by laboratory test results" 39 : 2266-2270, 1993
8 Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference" 37 : 1202-1219, 2003
9 Rambaldi A, "Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases" CD003620-, 2007
10 Newton JL, "Managing systemic symptoms in chronic liver disease" 1 (1): 46-55, 2012
1 Tamura A, "Yerba-mate (Ilex paraguariensis) extract prevents ethanol-induced liver injury in rats" 5 : 1714-1723, 2013
2 김지호, "Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K" 한국응용약물학회 21 (21): 234-240, 2013
3 Azevedo MF, "Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3" 24 (24): 220-224, 2010
4 Schwartz JE, "The measurement of fatigue:a new instrument" 37 : 753-762, 1993
5 Rambaldi A, "S-adenosyl-L-methionine for alcoholic liver diseases" CD002235-, 2006
6 Becker U, "Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study" 23 : 1025-1029, 1996
7 Conigrave KM, "Prediction of alcohol-related harm by laboratory test results" 39 : 2266-2270, 1993
8 Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference" 37 : 1202-1219, 2003
9 Rambaldi A, "Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases" CD003620-, 2007
10 Newton JL, "Managing systemic symptoms in chronic liver disease" 1 (1): 46-55, 2012
11 Lee DH, "Is serum gamma glutamyltransferase a marker of oxidative stress?" 38 : 535-539, 2004
12 YasudaM, "Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophages" 62 : 462-467, 2014
13 Nyblom H, "High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking" 39 : 336-339, 2004
14 Rehm J, "Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders" 373 : 2223-2233, 2009
15 Wilfred de Alwis NM, "Genetics of alcoholic liver disease and nonalcoholic fatty liver disease" 27 : 44-54, 2007
16 Swain MG, "Fatigue in liver disease: pathophysiology and clinical management" 20 : 181-188, 2006
17 Singh M, "Evaluation of the oxidative stress in chronic alcoholics" 7 : 1568-1571, 2013
18 Moreno C, "Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial" 53 : 1117-1122, 2010
19 Kajimoto O, "Effects of lentinus edodes mycelia-enriched diet on borderline and mild liver dysfunction:a double-blind, controlled study" 22 : 22-31, 2000
20 Bellentani S, "Drinking habits as cofactors of risk for alcohol induced liver damage" 41 : 845-850, 1997
21 Nishiguchi S, "Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease" 14 : 985-989, 1991
22 Thomson SJ, "Chronic liver disease—an increasing problem: a study of hospital admission and mortality rates in England, 1979–2005, with particular reference to alcoholic liver disease" 43 : 416-422, 2008
23 Vong S, "Chronic liver disease mortality in the United States, 1990–1998" 39 : 476-483, 2004
24 Lu Y, "Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice" 49 : 1406-1416, 2010
25 Ji Eun Shin, "Chalcones Isolated from Angelica keiskei and Their Inhibition of IL-6 Production in TNF-α-stimulated MG-63 Cell" 대한약학회 34 (34): 437-442, 2011
26 Kessova I, "CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury" 3 : 509-518, 2003
27 Bjelakovic G, "Antioxidant supplements for liver diseases" CD007749-, 2011
28 Lucey MR, "Alcoholic hepatitis" 360 : 2758-2769, 2009
29 Peterson B, "Alcohol consumption and premature death in middle-aged men" 280 : 1403-1406, 1980
30 Hickie IB, "A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome" 61 : 643-648, 2000